PMID- 20146002 OWN - NLM STAT- MEDLINE DCOM- 20100813 LR - 20211020 IS - 1875-8312 (Electronic) IS - 1569-5794 (Linking) VI - 26 IP - 5 DP - 2010 Jun TI - Low-dose CT and cardiac MR for the diagnosis of coronary artery disease: accuracy of single and combined approaches. PG - 579-90 LID - 10.1007/s10554-010-9595-2 [doi] AB - To prospectively compare the diagnostic performance of low-dose computed tomography coronary angiography (CTCA) and cardiac magnetic resonance imaging (CMR) and combinations thereof for the diagnosis of significant coronary stenoses. Forty-three consecutive patients with known or suspected coronary artery disease underwent catheter coronary angiography (CA), dual-source CTCA with prospective electrocardiography-gating, and cardiac CMR (1.5 Tesla). The following tests were analyzed: (1) low-dose CTCA, (2) adenosine stress-rest perfusion-CMR, (3) late gadolinium enhancement (LGE), (4) perfusion-CMR and LGE, (5) low-dose CTCA combined with perfusion-CMR, (5) low-dose CTCA combined with late gadolinium-enhancement, (6) low-dose CTCA combined with perfusion-CMR and LGE. CA served as the standard of reference. CA revealed >50% diameter stenoses in 68/129 (57.7%) coronary arteries in 29/43 (70%) patients. In the patient-based analysis, sensitivity, specificity, NPV and PPV of low-dose CTCA for the detection of significant stenoses were 100, 92.9, 100 and 96.7%, respectively. For perfusion-CMR and LGE, sensitivity, specificity, NPV, PPV, and accuracy were 89.7, 100, 82.4, and 100%, respectively. In the artery-based analysis, sensitivity and NPV of low-dose CTCA was significantly (P < 0.05) higher than that of perfusion-CMR and LGE. All combinations of low-dose CTCA and perfusion-CMR and/or LGE did not improve the diagnostic performance when compared to low-dose CTCA alone. Taking CA as standard of reference, low-dose CTCA outperforms CMR with regard to sensitivity and NPV, whereas CMR is more specific and has a higher PPV than low-dose CTCA. FAU - Scheffel, Hans AU - Scheffel H AD - Institute of Diagnostic Radiology, University Hospital Zurich, Raemistr 100, 8091, Zurich, Switzerland. hans.scheffel@usz.ch FAU - Stolzmann, Paul AU - Stolzmann P FAU - Alkadhi, Hatem AU - Alkadhi H FAU - Azemaj, Naim AU - Azemaj N FAU - Plass, Andre AU - Plass A FAU - Baumueller, Stephan AU - Baumueller S FAU - Desbiolles, Lotus AU - Desbiolles L FAU - Leschka, Sebastian AU - Leschka S FAU - Kozerke, Sebastian AU - Kozerke S FAU - Falk, Volkmar AU - Falk V FAU - Boesiger, Peter AU - Boesiger P FAU - Wyss, Christophe AU - Wyss C FAU - Marincek, Borut AU - Marincek B FAU - Donati, Olivio F AU - Donati OF LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100210 PL - United States TA - Int J Cardiovasc Imaging JT - The international journal of cardiovascular imaging JID - 100969716 RN - 0 (Contrast Media) RN - 0 (Vasodilator Agents) RN - 4419T9MX03 (Iohexol) RN - 712BAC33MZ (iopromide) RN - K72T3FS567 (Adenosine) SB - IM MH - Adenosine MH - Contrast Media MH - Coronary Angiography/*methods MH - Coronary Disease/*diagnosis/diagnostic imaging MH - Electrocardiography MH - Exercise Test MH - Female MH - Humans MH - Image Interpretation, Computer-Assisted MH - Iohexol/analogs & derivatives MH - Magnetic Resonance Angiography/*methods MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - Prospective Studies MH - Radiation Dosage MH - Sensitivity and Specificity MH - Tomography, X-Ray Computed/*methods MH - Vasodilator Agents EDAT- 2010/02/11 06:00 MHDA- 2010/08/14 06:00 CRDT- 2010/02/11 06:00 PHST- 2009/05/02 00:00 [received] PHST- 2010/01/20 00:00 [accepted] PHST- 2010/02/11 06:00 [entrez] PHST- 2010/02/11 06:00 [pubmed] PHST- 2010/08/14 06:00 [medline] AID - 10.1007/s10554-010-9595-2 [doi] PST - ppublish SO - Int J Cardiovasc Imaging. 2010 Jun;26(5):579-90. doi: 10.1007/s10554-010-9595-2. Epub 2010 Feb 10.